{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "MANAGEMENT OF ACUTE KIDNEY INJURY IN HOSPITAL"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-20248"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy and guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All health care professionals"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "10 November 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "09 November 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "NHS Patient Safety Alert NHS/PSA/D/2014/010 NICE Acute kidney injury: prevention, detection and management Clinical guideline [CG169] Published date: 28 August 2013"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Medicine"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Gowrie Balasubramaniam, Consultant Nephrologist Anthony Chan, Consultant Nephrologist Georgia Winnett, Consultant Nephrologist Jonathan Wong, Consultant Nephrologist Linda Lio, Renal Specialist Nurse"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2612 Basildon Hospital \u2612 Broomfield Hospital \u2612 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "MSE Renal Acute Reconfiguration Programme Board"
                    },
                    {
                        "text": "7 October 2020"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Fiona Ryan, Director of Operations Document Management Group"
                    },
                    {
                        "text": "01 April 2019"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "03 November 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "October 20"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2612 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Dr Aroon Lal"
                    },
                    {
                        "text": "Consultant Nephrologist, BUHT"
                    },
                    {
                        "text": "01 September 2020"
                    },
                    {
                        "text": "Dr Tom Hughes"
                    },
                    {
                        "text": "Consultant Nephrologist, BUHT"
                    },
                    {
                        "text": "01 September 2020"
                    },
                    {
                        "text": "MSE Kidney Consultants"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "01 September 2020"
                    },
                    {
                        "text": "Resuscitation and Deteriorating Patient Committee at SUH. Division 1(Medicine and Emergency Care) BTUH. MSE AKI workstream"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "01 April 2019"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Hyperkalaemia"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Gowrie Balasubramaniam, Anthony Chan, Georgia Winnett, Jonathan Wong, Linda Lio"
                    },
                    {
                        "text": "New guideline. Document supersedes Southend - CG304Management of Acute Kidney Injury (AKI) Broomfield 13007 Acute Kidney Injury"
                    },
                    {
                        "text": "10 November 2020"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Definition ....................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Definitions ..................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Role & Responsibilities within the Trust ........................................................................ 6"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Key Elements of Policy / Guideline ............................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Training Requirements ............................................................................................... 13"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Monitoring and Audit ................................................................................................... 13"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Approval and Implementation ..................................................................................... 14  Quality Impact Assessment ........................................................................................ 14  References ................................................................................................................. 15 Appendix 1: AKI Checklist .................................................................................................. 17 Appendix 2: MSE Pathway for the Management of AKI ..................................................... 18 Appendix 3: MSE AKI Care Bundle ................................................................................... 19 Appendix 4: Preliminary Equality Analysis ......................................................................... 20"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.1,
                "text": "Kidneys clean the blood by maintaining clearance, this is the passage of blood though millions of tiny filtering units called nephrons to create what will eventually become urine. Acute kidney injury (AKI) is the clinical syndrome caused by the abrupt loss of this function."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "The term acute kidney injury replaces all previous terminology such as acute renal failure or acute renal impairment. The AKI checklist (appendix 1) is required to be used in ALL patients with AKI in the trust and is to be utilised by ALL healthcare workers. The AKI pathway is shown in (appendix 2) to guide medical management of patients."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Definition"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Acute kidney injury currently defined by the rise in serum creatinine or a fall in urine output as follows:"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "type": "table",
            "sequence_num": 22,
            "data": {
                "num_rows": 4,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Stage"
                    },
                    {
                        "text": "Serum Creatinine"
                    },
                    {
                        "text": "Urine Output"
                    },
                    {
                        "text": "1"
                    },
                    {
                        "text": "1.5 to 1.9 X baseline OR \u2265 26.5 \u00b5mol/L increase"
                    },
                    {
                        "text": "< 0.5 ml/kg/hr for 6 to 12 hours"
                    },
                    {
                        "text": "2"
                    },
                    {
                        "text": "2.0 to 2.9 X baseline"
                    },
                    {
                        "text": "< 0.5 ml/kg/hr for \u2265 12 hours"
                    },
                    {
                        "text": "3"
                    },
                    {
                        "text": "3 X baseline OR \u2265 353.6 \u00b5mol/L increase OR Requiring RRT"
                    },
                    {
                        "text": "< 0.3mL/kg/hr for 24 hours or Anuria >12 hours"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Give guidance on patients in non-specialist areas such as A+E, acute admissions unit and adult general and medical/surgical wards"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Give brief advice for AKI in the community which is in line with the Royal College of General Practice guidance."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "Out of scope"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Hyperkalaemia in acute kidney injury is not covered in this guideline. Please refer to the Trust hyperkalaemia guidelines. Guideline on management of Hyperkalaemia"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This guideline applies to the management of acute kidney injury in adult patients only i.e. exclude paediatric AKI"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This guidance is for management of AKI in hospitals. For management of AKI in primary care please refer to RCGP guidance."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "type": "table",
            "sequence_num": 32,
            "data": {
                "num_rows": 22,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "RRT"
                    },
                    {
                        "text": "Renal Replacement Therapy (RRT) is therapy that replaces the normal blood filtering function of the kidneys."
                    },
                    {
                        "text": "Fistula"
                    },
                    {
                        "text": "An abnormal collection between two epithelialized surfaces that usually involves the gut and another hollow organ, such as the bladder, vagina, urethra or other regions of the GI tract. These can contribute to significant fluid loss."
                    },
                    {
                        "text": "NOAC"
                    },
                    {
                        "text": "Novel Oral Anticoagulants (NOAC) includes any of the newer anticoagulant drugs which are not vitamin K antagonists."
                    },
                    {
                        "text": "Prostatism"
                    },
                    {
                        "text": "A syndrome resulting from the compression or obstruction of the urethra, most commonly due to hyperplasia of the prostate."
                    },
                    {
                        "text": "ANCA"
                    },
                    {
                        "text": "Anti- Neutrophil Cytoplasmic Antibody"
                    },
                    {
                        "text": "ANA"
                    },
                    {
                        "text": "Anti \u2013 Nuclear Antibody"
                    },
                    {
                        "text": "ENA"
                    },
                    {
                        "text": "Extractable Nuclear Antigen Antibodies. An ENA panel test is used to help diagnose a multitude of autoimmune disorders like SLE and Sjogrens."
                    },
                    {
                        "text": "Anti-ds DNA"
                    },
                    {
                        "text": "Anti-Double Stranded DNA Antibody"
                    },
                    {
                        "text": "Anti-GBM"
                    },
                    {
                        "text": "Anti-Glomerular Basement membrane"
                    },
                    {
                        "text": "HUS / TTP"
                    },
                    {
                        "text": "Haemolytic Uraemic Syndrome / Thrombotic Thrombocytopenic Purpura"
                    },
                    {
                        "text": "Serum Electrophoresis (SPE)"
                    },
                    {
                        "text": "Screening test to measure major blood proteins by separating them into five distinct fractions."
                    },
                    {
                        "text": "Bence Jones protein"
                    },
                    {
                        "text": "A monoclonal globulin protein or immunoglobulin light chain found in urine. Detection may be suggestive of Multiple myeloma or Waldenstrom's macroglobulinemia"
                    },
                    {
                        "text": "Ayurveda"
                    },
                    {
                        "text": "A form of alternative medicine that is the traditional system of medicine in India"
                    },
                    {
                        "text": "Nephrostomy"
                    },
                    {
                        "text": "A procedure in which a flank incision is made so that a catheter can be inserted into the renal pelvis to drain the kidney, often done to relieve obstruction."
                    },
                    {
                        "text": "Hemofiltration"
                    },
                    {
                        "text": "A way to clean the blood typically done in the setting of intensive care in which there is convective transport of the solute through filtration across the membrane. This is different to dialysis where diffusion in the predominant method to clean the blood."
                    },
                    {
                        "text": "Asterixis"
                    },
                    {
                        "text": "An exaggerated muscle tremor characterised by involuntary jerking of the hand in flexion and extension."
                    },
                    {
                        "text": "e-GFR"
                    },
                    {
                        "text": "An estimate of the glomerular filtration rate (GFR) derived from serum creatinine, age, sex and race. It gives an estimate of renal function."
                    },
                    {
                        "text": "Uveitis"
                    },
                    {
                        "text": "Inflammation of the uveal tract: The iris, ciliary body and choroid of the eye."
                    },
                    {
                        "text": "Pyonephrosis"
                    },
                    {
                        "text": "An infection of the renal collecting system with collection of pus in the renal pelvis"
                    },
                    {
                        "text": "ACEi"
                    },
                    {
                        "text": "Angiotensin converting enzyme inhibitor"
                    },
                    {
                        "text": "ARB"
                    },
                    {
                        "text": "Angiotensin Receptor Blocker"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Role & Responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Individual responsibilities"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Harm prevention committee: Ensure appropriate management of AKI is undertaken to prevent further harm"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Renal directorate:"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure governance structure and systems in place for monitoring and reporting AKI, and managing severe AKI needing direct care under the renal service"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Individual responsibilities"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medical Directors: responsible for ensuring that all consultants aware of and comply with this policy."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consultant in charge of patients' care: ensure that the patient under their care has the appropriate care that is expected for patient that has an AKI."
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Junior Medical Staff:"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that appropriate pathways are executed"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure clear documentation in the notes, including the minimum entry for quality improvement processes."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "AKI Specialist Nurse"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Review in-hospital AKI stage 2 and 3 for active management"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Educate healthcare professionals in the trust about the AKI policy"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitor parameters in the trust that impact on AKI outcomes"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Working with other groups to improve hospital outcomes"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Liaising with the renal team"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Experienced Nurses or Allied Health Professionals:"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Key Elements of Policy / Guideline"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "NHS England AKI Algorithm"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.1  The Trust laboratory information management system is compliant with the Patient Safety Alert on the use of NHS England Acute Kidney Injury Detection Algorithm since 2014. This algorithm alerts clinicians on the possibility of AKI in their patients. This algorithm compares serum creatinine against available lowest serum creatinine"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "results within the last 7 days. If this is not available, it compares against the median serum creatinine in the last one year. In the absence of serum creatinine results in the past year, the algorithm then compares the serum creatinine with the appropriate age and sex based population interval. Clinicians will still have to use their diagnostic discretion in confirming the diagnosis and stage of AKI."
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.2,
                "text": "Causes of Acute Kidney Injury"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.2.1  The commonest precipitating events in hospital are sepsis and hypo-perfusion. The overall acute kidney injury is usually due to multiple factors and each factor has to be considered using the STOP acronym."
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "type": "table",
            "sequence_num": 57,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "Cause"
                    },
                    {
                        "text": "Specific causes (common)"
                    },
                    {
                        "text": "S"
                    },
                    {
                        "text": "Sepsis and Hypo-perfusion"
                    },
                    {
                        "text": "Pneumonia \uf0b7 Decreased intake Urosepsis \uf0b7 Increased fluid loss Peritonitis \uf0b7 Heart failure Hypovolaemia / Shock \uf0b7 Chronic Liver Disease"
                    },
                    {
                        "text": "T"
                    },
                    {
                        "text": "Toxins and Drugs"
                    },
                    {
                        "text": "Intravenous contrast \uf0b7 NSAIDS Gentamicin \uf0b7 ACE inhibitors, ARB Penicillin \uf0b7 Herbal"
                    },
                    {
                        "text": "O"
                    },
                    {
                        "text": "Obstruction"
                    },
                    {
                        "text": "Bladder outflow obstruction Pelvic Tumour Kidney stone"
                    },
                    {
                        "text": "P"
                    },
                    {
                        "text": "Primary kidney disease"
                    },
                    {
                        "text": "Glomerulonephritis (with systemic vasculitis or lupus) Myeloma Haemolytic-Uraemia Syndrome"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Table1. Causes of AKI"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.3,
                "text": "Assessment and Management of Acute Kidney Injury"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.3.1 Sepsis and Hypo-perfusion"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.3.2 The major categories of AKI in hospital are sepsis and hypo-perfusion. Treatment of the underlying process is the main goal."
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.3.3 Sepsis"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The sepsis seven care bundles should be initiated as early as possible. Multiple mechanisms, including hypo-perfusion, contribute to AKI in septicaemia."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Symptoms and potential source of infection: fever, cough, dysuria, diarrhoea, ulcers etc."
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Use the \u201cquick SEPSIS RELATED ORGAN FAILURE ASSESSMENT (qSOFA)\u201d if sepsis is suspected: altered mental state (GCS \u2264 15); fast respiratory state (RR \u2265 22), low blood pressure (SBP \u2264 100mmHg)"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Anti-biotic treatment should follow trust antibiotic guideline policy."
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Caution should be used with gentamicin dosing in the setting of AKI with Urosepsis, one off dosing of 1-2mg/kg with subsequent dosing determined by levels daily is ideal."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.3.4 Hypo-perfusion"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Conduct ABCDE assessment, including full set of observations, fluid status assessment, and EWS score."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Fluid intake and loss should be ascertained. Review available information (fluid charts and urine output). Commence strict input and output charts."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients that are predisposed to decreased intake are patients who are made nil by mouth, may not be able to drink by themselves or have a decreased thirst drive."
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Increased losses may occur in patients with a history of a diarrhoeal illness or output from fistula or a stoma."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "JVP, heart rate, blood pressure, capillary refill / peripheral perfusion"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Look for signs of shock i.e. SBP <90mmHg and/or low GCS. If the patient is well, a lying and standing may unmask volume depletion"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring if urine output is ideal but catherisation should be avoided if possible if it can be done by the patient themselves with the use of a fluid chart."
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Daily weights are the best assessment of overall fluid status of the patient in hospital."
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescribe fluids (oral or intra-venous)"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Target blood pressure should be set and use of inotropes / vasopressors should be considered early if hypotension is not responding to fluid resuscitation."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients with severe heart failure, chronic liver disease and nephrotic syndrome have a low effective circulating volume and are a difficult group of patients to manage. Specialist advice should be sought (nephrology, cardiology, gastroenterology, high-dependency/intensive care)."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Renal artery stenosis can cause an AKI in a setting of systemic hypo- perfusion or if angiotensin converting enzyme inhibitors or angiotensin receptors blockers are started."
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "Toxin / Drugs"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A detailed drug history should be obtained to consider potential causes or contributory medications of AKI."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ask about drugs bought over the counter such as non-prescription pain killers or herbal medications (ordered over the internet as food supplements, Chinese, Indian Ayurveda)."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Common direct kidney toxins that should ideally be avoided or their use minimised in \u201cat risk\u201d patients (see below) are:"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Some drugs may contribute to AKI in certain circumstances;"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Drug that are eliminated (or cleared) by the kidneys that may become toxic by accumulation in AKI."
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Metformin should usually be stopped as it can exacerbate acidosis"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Insulin may need to be reduced as it may precipitate hypoglycaemia (Insulin is excreted by the kidneys). T1DM should never have insulin stopped completely."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Rarely, a specific drug can cause an \u201callergic reaction in the kidney\u201d and this may coincide with the initiation of a new drug or a known previously allergy to a drug such as penicillin or vancomycin. A raised eosinophil count of the full blood count is suggestive of this."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Certain chemotherapy agents and specialist anti-biotic / antifungals / anti-viral can cause AKI. A more detailed summary of drugs in relation to AKI is provided by the think kidneys campaign. Specific advice can be given by the members of the pharmacy team and there is Think Kidneys guidance associated with these trust guidelines."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.5,
                "text": "Obstruction"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Benign prostatic hyperplasia is an easily treatable cause of obstruction that still remains a cause of acute and chronic kidney injury. A history of \u201cprostatism\u201d (or voiding symptoms) such as difficulty initiation of micturition, poor stream or terminal dribbling should point to a bladder outflow obstruction."
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Older women can get bladder outflow obstruction due to cervical insufficiency, especially if there is a history of multiple vaginal deliveries, and input from gynaecology is required to manage this."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Constipation is a common cause of bladder outflow obstruction in older, frail people who may be bed-bound. A volume of 350mls post micturition may suggest underlying obstruction and urinary catheter should be considered to relieve obstruction."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients with a history of renal stones or presenting with renal colic should always be considered for urgent management with intravenous fluid administration and an urgent ultrasound (<24 hours). If concurrent infection, i.e. pyonephrosis, is suspected, ultrasound should be done immediately if decompression is planned (even out of hours)."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients with a pelvic malignancy or pelvic disease in metastatic cancer are at risk of obstruction, and an urgent (<24 hours) ultrasound should be obtained in these patients with input from the relevant oncology team."
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.6,
                "text": "Primary Kidney Disease"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This is an infrequent cause of AKI but early recognition is important as potential lifesaving or kidney saving treatment needs to be instituted early. It is beyond the scope of this guidance to go into details of condition this group encompasses by a brief overview is given to facilitate early discussion with the relevant specialty."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Look for potential systemic disease such as a vasculitis (haemoptysis, rash, uveitis, arthritis). Patient may have a history of an auto-immune condition. Patients can be generally well will no sign of any other cause."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Suspect AKI due to primary kidney disease if urine dip has significant quantities of blood and protein. Perform Acute Renal Screen: ANA, ANCA, Anti-GBM, Complements and Cryoglobulins, Creatine Kinase, LDH and peripheral blood film (if HUS/TTP suspected), serum protein electrophoresis, serum free light chains and urine for Bence Jones protein."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Multiple myeloma is a common cause in the older person and can be missed if not specifically looked for. This can occur in older people if there is no other obvious cause, there may be concurrent abnormal full blood count (anaemia), hypercalcaemia or raised serum total protein."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.7,
                "text": "Summary of Investigations and management in AKI"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "type": "table",
            "sequence_num": 103,
            "data": {
                "num_rows": 7,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Cause"
                    },
                    {
                        "text": "Investigations"
                    },
                    {
                        "text": "Management"
                    },
                    {
                        "text": "Sepsis and Hypo- perfusion"
                    },
                    {
                        "text": "Urine MC+S Stool MC+S Sputum MC+S Blood culture ECG Echocardiogram Chest X ray"
                    },
                    {
                        "text": "Antibiotics Resuscitation / Volume repletion Inotropes"
                    },
                    {
                        "text": "Toxin"
                    },
                    {
                        "text": "Drug history Full blood count (eosinophils)"
                    },
                    {
                        "text": "Stop all toxins and potential drugs that may compound further injury to kidney. Modify doses of prescribed medications if required."
                    },
                    {
                        "text": "Obstruction"
                    },
                    {
                        "text": "Bladder scan Ultrasound"
                    },
                    {
                        "text": "Bladder catheterisation Nephrostomy"
                    },
                    {
                        "text": "Primary Kidney Disease"
                    },
                    {
                        "text": "Disease specific treatment such as immunosuppression, chemotherapy or plasma exchange. (involve specialist teams)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Table 2 Management of AKI"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.8,
                "text": "Complications of AKI"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.1 The main complications that have to be managed with an AKI are hyperkalaemia, acidosis, volume overload, and uraemia. The mainstay of treatment should be the treatment of the underlying cause. Severe manifestations of complications should warrant consideration of renal replacement and discussion with the renal team or intensive care unit."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.2 Hyperkalaemia"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Refer to Hyperkalaemia guidelines"
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.3 Acidosis"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Acidosis needs to be treated by renal replacement; isotonic (1.26%, or 1.4%) sodium bicarbonate can be used with senior advice to help manage hyperkalaemia."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.4 Uraemia"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Uraemic encephalopathy or pericarditis are rare but is an indication for renal replacement. Uraemic encephalopathy can manifest as an acute confusion and the patient may have an Asterixis. A pericardial rub may be present in pericarditis."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.5 Volume overload"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The danger is precipitating fluid overload which has been shown to cause worse outcomes in patients with AKI."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The only way of fluid removal in a patient with oliguria renal failure is by using renal replacement such as Hemofiltration or dialysis."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.6 Pulmonary Oedema"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.0,
                "text": "Sit the patient up and give oxygen  L/min through non-rebreathe mask, and then titrate according to ABG results."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If haemodynamic ally stable give furosemide 80mg IV"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If haemodynamic ally stable commence GTN 1-10mg/hour titrating dose."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.9,
                "text": "High risk population"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.9.1 Certain groups of patients are at risk of AKI and consideration should be given to prevent an AKI in the first instance or institute management as early as possible (i.e. before blood results are available)."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.9.2 These  patients  should  be  counselled  for  sick  day  rules  where  ACEI/ARB  and diuretics should be withheld temporarily during periods of inter-current illness."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "type": "table",
            "sequence_num": 123,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Patient specific \u2013 Susceptibility Older age \uf0b7 Past history of AKI Hypovolaemia, dehydration, reduced \uf0b7 Neurological or cognitive oral intake impairment or disability, which may Hypotension mean limited access to fluids Sepsis because of reliance on a carer CKD (eGFR <60) \uf0b7 Symptoms or history of urinary tract Diabetes mellitus obstruction, or conditions that may Heart failure lead to obstruction Liver disease \uf0b7 Immunosuppressed or deficient immunity e.g. malnutrition, patients with cancer"
                    },
                    {
                        "text": "Situation specific \u2013 Susceptibility Post-operative Use of iodinated contrast agents within the past week Use of drugs such as non-steroidal anti- inflammatory drugs [NSAIDs], angiotensin- converting enzyme [ACE] inhibitors, angiotensin II receptor antagonists [ARBs] and diuretics) within the past week, especially if hypovolaemic Poor access to fluids i.e. bed bound"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Table 3. High risk population for AKI"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "General guidance to minimise AKI with intravenous contrast administration"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.10.1 Contrast induced AKI may have been previously overestimated as many patients who develop AKI post contrast exposure in an acute setting have a scan in a setting of an acute illness which could cause AKI. The term contrast associated AKI is now being used to as replacement to highlight this point."
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.10.2 The AMACING study data suggests that there is no evidence for routine use of intravenous hydration in patients with eGFR >30 ml/min/1.73m3. The PRESERVE study also did not show any benefit in patients who received sodium bicarbonate or normal saline over placebo. A prior called POSEIDON demonstrated benefit in haemodynamic-guided fluid administration for patients at risk of AKI defined by eGFR <60 ml/min/1.73m3."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "6.10.3 A reasonable stance is the the patients with eGFR <  or other factor that make them at risk must be adequately volume replete before exposure. At-risk in-patients (table 3) who are volume deplete or euvolaemic may benefit from intravenous hydration (suggested regime of 1L  hours before and 1L  hours after for in- patients) and withholding diuretics, ACE/ARB, and other nephrotoxic agents. We would not anticipate out-patients to be volumes deplete and oral hydration should be encouraged if there is risk."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "Currently training is undertaken on an ad hoc basis with teaching sessions by AKI Specialist Nurse and renal doctors."
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "type": "table",
            "sequence_num": 133,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Numbers of AKI stage 1, 2 and 3 from biochemistry"
                    },
                    {
                        "text": "MSE Kidney Governan ce"
                    },
                    {
                        "text": "Renal"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "MSE Kidney Governance meeting"
                    },
                    {
                        "text": "Renal"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 134,
            "data": {
                "num_rows": 4,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "system (sent to renal registry)"
                    },
                    {
                        "text": "meeting"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Deterioration of AKI stage 1 and 2 to 2 and 3, respectively"
                    },
                    {
                        "text": "MSE Kidney Governan ce meeting"
                    },
                    {
                        "text": "Renal"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "MSE Kidney Governance meeting"
                    },
                    {
                        "text": "Renal"
                    },
                    {
                        "text": "AKI pathways used for AKI"
                    },
                    {
                        "text": "MSE Kidney Governan ce meeting"
                    },
                    {
                        "text": "Renal"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "MSE Kidney Governance meeting"
                    },
                    {
                        "text": "Renal"
                    },
                    {
                        "text": "Mortality and length of stay for AKIs"
                    },
                    {
                        "text": "MSE Kidney Governan ce meeting"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "All policies, procedures and guidelines will be approved by the renal consultants in conjunction with the AKI clinical specialist nurses across the MSE group of hospitals. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "It is the author's responsibility to inform the MSE renal consultants and the AKI nurses of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Quality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "type": "table",
            "sequence_num": 139,
            "data": {
                "num_rows": 4,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Benefits"
                    },
                    {
                        "text": "What evidence has been used to develop this proposal e.g. NICE, NCEPOD, audit, patient or staff surveys?"
                    },
                    {
                        "text": "NICE www.nice.org.uk/guidance/CG169"
                    },
                    {
                        "text": "What changes does this proposal make to the care pathway?"
                    },
                    {
                        "text": "Pathway to be enacted more robustly"
                    },
                    {
                        "text": "Describe the positive impact on: Patient safety Clinical effectiveness Patient experience"
                    },
                    {
                        "text": "This will ensure that pathway is applied to all patients, thereby, ensuring minimum standard of care for patients with AKI."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 140,
            "data": {
                "num_rows": 6,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "What current or new clinical outcome measures will monitor these benefits?"
                    },
                    {
                        "text": "As per monitoring and audit in section 7"
                    },
                    {
                        "text": "Impact Assessment"
                    },
                    {
                        "text": "Describe how the impact of the change has been considered in relation to: Infection Prevention and Control Safeguarding vulnerable adults/ children Current quality indicators Quality Account priorities Patients/ carers/ members of the public Promoting self-care for people with long-term conditions Tackling health inequalities"
                    },
                    {
                        "text": "Acute renal failure mortality is shown in the SHMI data which is open to public and where the hospital is held accountable. Ensuring standard care is applied with tackle inequalities at different times of the day / week."
                    },
                    {
                        "text": "How will you monitor the impact of this proposal? Provide details of how this will be done, by whom, and when."
                    },
                    {
                        "text": "These are described in the audit and monitoring section"
                    },
                    {
                        "text": "Trigger points early warning indicators"
                    },
                    {
                        "text": "Worsening rate of deterioration of AKI"
                    },
                    {
                        "text": "Escalate to? When? Responsible person"
                    },
                    {
                        "text": "AKI lead for the trust."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National  Institute  for  Health  and  Care  Excellence  (NICE).  Acute  Kidney  Injury: prevention, detection and management (cg169). London: NICE, 2013"
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017 Apr 1;389(10076):1312- 1322. doi: 10.1016/S0140-6736(17)30057-0"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Weisbord  SD,  Gallagher  M,  Jneid  H,  et  al.  for  the  PRESERVE  Trial  Group. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med 2018; 378:603-614. doi: 10.1056/NEJMoa1710933"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Brar S, Aharonian V, Mansukhani P, Moore N, Shen A, Jorgensen M, Dua A, Short L, Kane K. Haemodynamic-guided fluid administration for the prevention of contrast- induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014 May 24;383(9931):1814-23. doi: 10.1016/S0140-6736(14)60689-9."
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "https://www.thinkkidneys.nhs.uk/aki/wp- content/uploads/sites/2/2016/10/RespondingtoAKI-Warning-Stage-Test-Results-for- Adults-in-Primary-Care.pdf"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "http://www.rcgp.org.uk/aki http://elearning.rcgp.org.uk/course/info.php?id=213"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "https://www.thinkkidneys.nhs.uk/aki/wp-content/uploads/sites/2/2016/07/Primary- Care-Advice-for-medication-review-in-AKI-.pdf"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "https://www.thinkkidneys.nhs.uk/aki/wp-content/uploads/sites/2/2016/02/When-to- restart-drugs-stopped-during-AKI-final.pdf"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "https://www.thinkkidneys.nhs.uk/aki/wp-content/uploads/sites/2/2017/10/Changes- in-Kidney-Function-FINAL.pdf"
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "text": "https://www.thinkkidneys.nhs.uk/aki/wp-content/uploads/sites/2/2016/02/BKPA- Patient-at-Risk-Leaflet_Printout.pdf"
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "text": "https://www.thinkkidneys.nhs.uk/aki/wp-content/uploads/sites/2/2015/11/BKPA- RCGP-A4-Printout-Leaflet_v4.pdf"
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: AKI Checklist"
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The AKI checklist is mandated for the management of AKI by all healthcare staff"
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "type": "image",
            "sequence_num": 155,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.004.jpeg"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: MSE Pathway for the Management of AKI"
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "type": "image",
            "sequence_num": 157,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.005.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Management of Acute Kidney Injury in Hospital/ MSEPO-20248/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Describe how the impact of the change has been considered in relation to:"
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Infection Prevention and Control"
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "type": "image",
            "sequence_num": 161,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safeguarding vulnerable adults/ children"
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "type": "image",
            "sequence_num": 163,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Current quality indicators"
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "type": "image",
            "sequence_num": 165,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Quality Account priorities"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "type": "image",
            "sequence_num": 167,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients/ carers/ members of the"
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "type": "image",
            "sequence_num": 169,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "public"
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Promoting self-care for people with"
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "type": "image",
            "sequence_num": 172,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "long-term conditions"
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Tackling health inequalities"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "type": "image",
            "sequence_num": 175,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: MSE AKI Care Bundle"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "type": "image",
            "sequence_num": 178,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.002.png"
            }
        },
        {
            "type": "image",
            "sequence_num": 179,
            "data": {
                "url": "MSEPO-20248 Management of Acute Kidney Injury in MSE hospital 1.0.006.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Management of Acute Kidney Injury in Hospital/ MSEPO-20248/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 4: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Management of Acute Kidney Injury in Hospital/CG304: (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "type": "table",
            "sequence_num": 183,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2612 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2610 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 184,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Management of hyperkalaemia to be in line with national guidance"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "National Patient Safety Alert for AKI and NICE guidelines on AKI"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients who have this common medical complication will have clear consistent treatment in line with national guidance"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Discussed with MSE Renal Consultant body. Once approved, we will encourage adoption by all medical staff"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 185,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "G Balasubramaniam"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Consultant Nephrologist"
                    },
                    {
                        "text": "09 November 2020"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 187
        }
    ]
}